
Processa Pharmaceuticals, Inc.
PCSANasdaqCIK 1533743HealthcareFiscal year ends Dec 31
Reports and events: 260 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2020-07-1717:25 ET | S-1/A | Registration statement, amended | 0001493152-20-013568 |
| 2020-06-0107:01 ET | 8-K | 1.01 Entry into a material agreement | 0001493152-20-010206 |
| 2020-05-2822:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-20-009985 |
| 2020-05-1513:23 ET | 10-Q | Quarterly reportPeriod 2020-03-31 | 0001493152-20-009002 |
| 2020-03-3016:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-20-005196 |
| 2020-03-1709:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-20-004116 |
| 2020-03-0617:17 ET | 10-K | Annual reportPeriod 2019-12-31 | 0001493152-20-003534 |
| 2020-03-0509:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-20-003415 |
| 2020-02-2509:30 ET | 8-K | 8.01 Other events | 0001493152-20-002918 |
| 2020-02-1309:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-20-002171 |
| 2020-01-1414:20 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-20-000565 |
| 2019-12-2016:20 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-19-019526 |
| 2019-12-1317:32 ET | S-1 | Registration statement | 0001493152-19-019202 |
| 2019-11-1411:45 ET | 10-Q | Quarterly reportPeriod 2019-09-30 | 0001493152-19-017267 |
| 2019-10-2307:20 ET | 8-K | 7.01 Regulation FD disclosure | 0001493152-19-015853 |
| 2019-10-0317:47 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001493152-19-014907 |
| 2019-09-0417:19 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-19-013686 |
| 2019-08-1412:14 ET | 10-Q | Quarterly reportPeriod 2019-06-30 | 0001493152-19-012368 |
| 2019-06-2119:51 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-19-009519 |
| 2019-06-0709:00 ET | 8-K | 7.01 Regulation FD disclosure | 0001493152-19-008837 |
| 2019-05-1413:08 ET | 10-Q | Quarterly reportPeriod 2019-03-31 | 0001493152-19-007021 |
| 2019-04-2617:02 ET | DEF 14A | Proxy statementPeriod 2019-04-26 | 0001493152-19-006019 |
| 2019-04-0821:40 ET | 10-K/A | Annual report, amendedPeriod 2018-12-31 | 0001493152-19-004990 |
| 2019-03-2817:25 ET | 10-K | Annual reportPeriod 2018-12-31 | 0001493152-19-004137 |
| 2019-03-1307:49 ET | 8-K | 7.01 Regulation FD disclosure | 0001493152-19-003235 |
| 2019-02-2506:02 ET | 8-K | 7.01 Regulation FD disclosure | 0001493152-19-002474 |
| 2019-01-0909:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-19-000348 |
| 2018-12-0609:00 ET | 8-K | 3.01 Delisting notice; 8.01 Other events | 0001493152-18-017091 |
| 2018-11-1421:37 ET | 10-Q | Quarterly reportPeriod 2018-09-30 | 0001493152-18-015821 |
| 2018-10-3016:19 ET | S-1/A | Registration statement, amended | 0001493152-18-014994 |
| 2018-10-0917:32 ET | S-1/A | Registration statement, amended | 0001493152-18-014282 |
| 2018-10-0320:40 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-18-014019 |
| 2018-09-1416:13 ET | S-1/A | Registration statement, amended | 0001493152-18-013266 |
| 2018-09-1009:26 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-18-013033 |
| 2018-08-1417:29 ET | 10-Q | Quarterly reportPeriod 2018-06-30 | 0001493152-18-011912 |
| 2018-07-3016:22 ET | S-1 | Registration statement | 0001493152-18-010649 |
| 2018-07-0617:29 ET | 8-K | 1.01 Entry into a material agreement | 0001493152-18-009782 |
| 2018-06-0409:15 ET | 8-K | 7.01 Regulation FD disclosure | 0001493152-18-008158 |
| 2018-06-0108:26 ET | 8-K | 1.01 Entry into a material agreement | 0001493152-18-008107 |
| 2018-05-2112:42 ET | 10-Q | Quarterly reportPeriod 2018-03-31 | 0001493152-18-007514 |
| 2018-04-1714:02 ET | 10-K/A | Annual report, amendedPeriod 2017-12-31 | 0001493152-18-005289 |
| 2018-04-1616:58 ET | 10-K | Annual reportPeriod 2017-12-31 | 0001493152-18-005248 |
| 2018-03-3021:06 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001493152-18-004197 |
| 2018-01-2410:57 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001493152-18-000954 |
| 2017-12-1517:07 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001393905-17-000400 |
| 2017-12-0619:17 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001393905-17-000391 |
| 2017-11-2015:33 ET | 10-Q | Quarterly reportPeriod 2017-09-30 | 0001393905-17-000369 |
| 2017-11-0215:53 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001393905-17-000335 |
| 2017-10-3017:27 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001393905-17-000333 |
| 2017-10-2014:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001393905-17-000325 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 23:30 ET. Listed shows no prices and gives no investment advice.